DIAGNOSTICS OF BONE METABOLISM DISORDERS IN ONCOLOGICAL DISEASES

Osteoporosis is one of the most significant bone complications of cancer. About 1.5 million cancer patients worldwide have bone metastases. Patients with myeloma, breast cancer, prostate, thyroid, bladder and lung have very high risk of development of bone lesions and related complications. Currentl...

Full description

Saved in:
Bibliographic Details
Main Authors: O. I. Apolikhin, B. Y. Alekseev, A. V. Sivkov, N. G. Keshishev, A. A. Trudov, E. Z. Rabinovich, A. A. Kachmazov
Format: Article
Language:Russian
Published: QUASAR, LLC 2016-01-01
Series:Исследования и практика в медицине
Subjects:
Online Access:https://www.rpmj.ru/rpmj/article/view/107
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1839573550753644544
author O. I. Apolikhin
B. Y. Alekseev
A. V. Sivkov
N. G. Keshishev
A. A. Trudov
E. Z. Rabinovich
A. A. Kachmazov
author_facet O. I. Apolikhin
B. Y. Alekseev
A. V. Sivkov
N. G. Keshishev
A. A. Trudov
E. Z. Rabinovich
A. A. Kachmazov
author_sort O. I. Apolikhin
collection DOAJ
description Osteoporosis is one of the most significant bone complications of cancer. About 1.5 million cancer patients worldwide have bone metastases. Patients with myeloma, breast cancer, prostate, thyroid, bladder and lung have very high risk of development of bone lesions and related complications. Currently, osteodensitometry is the gold standard for the diagnosis of osteoporosis. In recent years we frequently use the innovative imaging techniques for bone metastases, such as CT, MRI, PET/CT. Unfortunately, the diagnostic value of these methods is that it is not always possible to identify abnormalities of bone metabolism in cancer, especially in the early stages. This review shows the world experience of usage of biochemical markers of bone resorption (calcium, hydroxyproline, NTX, CTX, PYD, DPD, TRAP-5b, bone sialoprotein - BSP) and markers of bone synthesis (osteocalcin, CSF, ACF, Karlovy vary IFF), their advantages and disadvantages. The level of these markers is increased in most patients with osteoporosis and bone metastases, it is suggesting a potential role in early diagnosis of bone metastases.
format Article
id doaj-art-4953e1b5bc3c47a2802bd74bdf9da6c8
institution Matheson Library
issn 2410-1893
language Russian
publishDate 2016-01-01
publisher QUASAR, LLC
record_format Article
series Исследования и практика в медицине
spelling doaj-art-4953e1b5bc3c47a2802bd74bdf9da6c82025-08-04T14:04:02ZrusQUASAR, LLCИсследования и практика в медицине2410-18932016-01-0124889710.17709/2409-2231-2015-2-4-88-9779DIAGNOSTICS OF BONE METABOLISM DISORDERS IN ONCOLOGICAL DISEASESO. I. Apolikhin0B. Y. Alekseev1A. V. Sivkov2N. G. Keshishev3A. A. Trudov4E. Z. Rabinovich5A. A. Kachmazov6N. Lopatkin Scientific Research Institute of Urology and Interventional Radiology – branch of the National Medical Research Radiological Centre of the Ministry of Health of the Russian Federation 3rd Parkovaya ulitsa 51/4, Moscow, 105425, RussiaN. Lopatkin Scientific Research Institute of Urology and Interventional Radiology – branch of the National Medical Research Radiological Centre of the Ministry of Health of the Russian Federation 3rd Parkovaya ulitsa 51/4, Moscow, 105425, RussiaN. Lopatkin Scientific Research Institute of Urology and Interventional Radiology – branch of the National Medical Research Radiological Centre of the Ministry of Health of the Russian Federation 3rd Parkovaya ulitsa 51/4, Moscow, 105425, RussiaN. Lopatkin Scientific Research Institute of Urology and Interventional Radiology – branch of the National Medical Research Radiological Centre of the Ministry of Health of the Russian Federation 3rd Parkovaya ulitsa 51/4, Moscow, 105425, RussiaN. Lopatkin Scientific Research Institute of Urology and Interventional Radiology – branch of the National Medical Research Radiological Centre of the Ministry of Health of the Russian Federation 3rd Parkovaya ulitsa 51/4, Moscow, 105425, RussiaN. Lopatkin Scientific Research Institute of Urology and Interventional Radiology – branch of the National Medical Research Radiological Centre of the Ministry of Health of the Russian Federation 3rd Parkovaya ulitsa 51/4, Moscow, 105425, RussiaN. Lopatkin Scientific Research Institute of Urology and Interventional Radiology – branch of the National Medical Research Radiological Centre of the Ministry of Health of the Russian Federation 3rd Parkovaya ulitsa 51/4, Moscow, 105425, RussiaOsteoporosis is one of the most significant bone complications of cancer. About 1.5 million cancer patients worldwide have bone metastases. Patients with myeloma, breast cancer, prostate, thyroid, bladder and lung have very high risk of development of bone lesions and related complications. Currently, osteodensitometry is the gold standard for the diagnosis of osteoporosis. In recent years we frequently use the innovative imaging techniques for bone metastases, such as CT, MRI, PET/CT. Unfortunately, the diagnostic value of these methods is that it is not always possible to identify abnormalities of bone metabolism in cancer, especially in the early stages. This review shows the world experience of usage of biochemical markers of bone resorption (calcium, hydroxyproline, NTX, CTX, PYD, DPD, TRAP-5b, bone sialoprotein - BSP) and markers of bone synthesis (osteocalcin, CSF, ACF, Karlovy vary IFF), their advantages and disadvantages. The level of these markers is increased in most patients with osteoporosis and bone metastases, it is suggesting a potential role in early diagnosis of bone metastases.https://www.rpmj.ru/rpmj/article/view/107osteoporosisdiagnosis of osteoporosisbiochemical markersbone metastasesbone resorptionsynthesis of bone tissue
spellingShingle O. I. Apolikhin
B. Y. Alekseev
A. V. Sivkov
N. G. Keshishev
A. A. Trudov
E. Z. Rabinovich
A. A. Kachmazov
DIAGNOSTICS OF BONE METABOLISM DISORDERS IN ONCOLOGICAL DISEASES
Исследования и практика в медицине
osteoporosis
diagnosis of osteoporosis
biochemical markers
bone metastases
bone resorption
synthesis of bone tissue
title DIAGNOSTICS OF BONE METABOLISM DISORDERS IN ONCOLOGICAL DISEASES
title_full DIAGNOSTICS OF BONE METABOLISM DISORDERS IN ONCOLOGICAL DISEASES
title_fullStr DIAGNOSTICS OF BONE METABOLISM DISORDERS IN ONCOLOGICAL DISEASES
title_full_unstemmed DIAGNOSTICS OF BONE METABOLISM DISORDERS IN ONCOLOGICAL DISEASES
title_short DIAGNOSTICS OF BONE METABOLISM DISORDERS IN ONCOLOGICAL DISEASES
title_sort diagnostics of bone metabolism disorders in oncological diseases
topic osteoporosis
diagnosis of osteoporosis
biochemical markers
bone metastases
bone resorption
synthesis of bone tissue
url https://www.rpmj.ru/rpmj/article/view/107
work_keys_str_mv AT oiapolikhin diagnosticsofbonemetabolismdisordersinoncologicaldiseases
AT byalekseev diagnosticsofbonemetabolismdisordersinoncologicaldiseases
AT avsivkov diagnosticsofbonemetabolismdisordersinoncologicaldiseases
AT ngkeshishev diagnosticsofbonemetabolismdisordersinoncologicaldiseases
AT aatrudov diagnosticsofbonemetabolismdisordersinoncologicaldiseases
AT ezrabinovich diagnosticsofbonemetabolismdisordersinoncologicaldiseases
AT aakachmazov diagnosticsofbonemetabolismdisordersinoncologicaldiseases